Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New stroke care program aims to cut complications and boost recovery

NCT ID NCT07627399

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a nurse-led program called BEST CARE ICTUS_HC for adults hospitalized with acute stroke in hospitals without specialized stroke units. The program includes staff training, swallowing tests, and environmental adaptations to help with attention and safety. Researchers will compare outcomes like swallowing detection, neglect severity, and quality of life up to 6 months after discharge between patients receiving the program and those receiving usual care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
BEST CARE ICTUS_HC bundle (nurse training, swallowing screening, environmental adaptations, and monitoring protocols)
What this could lead to
If successful, this program could reduce complications like pneumonia and improve quality of life for stroke patients in general hospitals.
What could go wrong
This is a cluster-randomized trial testing a care bundle, not a new drug. Results may vary across hospitals and may not apply to all stroke patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 700 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2026

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients aged 18 years or older. * Clinical diagnosis of acute ischemic or hemorrhagic stroke. * Admission to conventional hospitalization units (Internal Medicine) in regional hospitals without specialized Stroke Units. Exclusion Criteria: * Patients admitted for a cause other than stroke who develop a stroke during their hospital stay (in-hospital stroke). * Patients subjected to invasive neurological procedures. * Patients undergoing invasive procedures, such as thrombectomy, who require transfer to a referral hospital and remain there for more than 48 hours. * Patients with deterioration of the level of consciousness that prevents the performance of dysphagia testing. * Patients that have been taken care of by Nurses and Nursing Assistants with \>4 weeks of work experience in Stroke Units in the last 12 months

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acute hemorrhagic stroke are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    4 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Hospital Comarcal de la Axarquia

    RECRUITING

    Málaga, Velez-Maálaga, 29700, Spain

  • Hospital Universitario Costa del Sol

    NOT_YET_RECRUITING

    Marbella, Málaga, 29603, Spain

  • Hospital de Antequera

    NOT_YET_RECRUITING

    Antequera, Málaga, 29200, Spain

  • Hospital de la Serranía de Ronda

    NOT_YET_RECRUITING

    Ronda, Málaga, 29400, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.